Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

This study tested a new pill called TQB3909 in 19 adults with mantle cell lymphoma that had returned or stopped responding to other treatments. The main goal was to find a safe dose and check for side effects. The trial was stopped early, so results are limited.

This early-stage study tested the safety of a new drug called AP026 in healthy adults. The trial was stopped before completion, so we don't know if the drug works for type 2 diabetes. The main goal was to check for side effects and how the body processes the drug.